PAIGE HAMILTON: Open Payments
NPI 1245447820 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 17 payments from 9 companies in 2025. Trend: 2023 $122 · 2024 $269 · 2025 $440
Food & beverage: $374Education: $66
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $84 |
| Vanda Pharmaceuticals Inc. | 2 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Alkermes, Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
Products named: FANAPT, COBENFY, INVEGA SUSTENNA, VRAYLAR, INGREZZA, LYBALVI, CAPLYTA, ARISTADA.
Industry payments across AZ — which companies pay providers there.
